Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.